DOCSLIB.ORG

Getinge Ethics & Compliance Report

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Getinge Ethics & Compliance Report FIRST EDITION JULY 2021 Passion for life Getinge Ethics & Compliance Report Content INTRO THE TEAM BUSINESS CONTEXT THE FRAMEWORK FOCUS AREAS Vision 1 Message from the EVP Legal, Global Trends 9 Our Code of Conduct 11 Anti-Bribery Corruption 15 Business Ethics and Compliance & Governance 4 Lessons Learned in Brazil 10 Our E&C Program 12 Antitrust 17 Responsible Leadership 2 Organization 5 Creating a Speak Up Business Partners 19 Meet the E&C Team 6 Culture 14 Data Privacy 21 Interaction with Health Care Professionals 24 Trade Compliance 26 For more information about our Getinge AB (publ) sustainability work, governance and Lindholmspiren 7A GRI Index, see our Annual Report 2020 P.O. Box 8861 and our Sustainability Update 2020. SE-402 72, Gothenburg For further information regarding Sweden Ethics & Compliance issues, please Passion for life Passion for life contact [email protected] Tel: +46 (0)10 335 00 00 2020 Annual Report 2020 Sustainability Update E-mail: [email protected] www.getinge.com Intro The Team Business Context Governance Focus Areas Ethics & Compliance Report VISION Becoming the World’s most Trusted and Respected MedTech Company Our vision is to become the world’s most trusted and standards in everything we do. This comes with some respected medtech company. This guides everything heavy responsibility. Just as people trust doctors to we do. Getinge provides products and solutions that do the right thing, our stakeholders trust us to do the help saving lives around the world. Our continued suc- right thing. This report aims for demonstrating how we cess in providing these life-saving products depends build and maintain this trust. on each member of the staff upholding the highest 1 Intro The Team Business Context Governance Focus Areas Ethics & Compliance Report Business Ethics and Responsible Leadership Business Ethics & Responsible Leadership At Getinge, responsible leadership means involving all employees to set the standard and acting as role Getinge has long been dedicated to sustainability, and since 2017 sustainability, models for ethical behavior and professional integrity. together with quality, is a top priority in the company’s strategy. This means that Activities in this area provide the conditions and requirements for Getinge’s employees to ensure ethics, quality and sustainability are integral parts of how the company acts as a business is conducted in an ethical and responsible manner. Doing responsible business in all relations, business and how it treats its employees, customers and partners. in the company’s own organization and in external contexts, is a key part of Getinge’s strategy. In 2020, Getinge raised its sustainability ambitions, which is described in the company’s Sustainability Framework covering the focus areas of Quality Culture, Passionate Employees, 3 Environmental & Social Engagement Capitalize on having one Quality Culture and Business Ethics & Responsible truly global brand 4 Leadership. Environmental & Social Capture global Engagement The Sustainability Framework growth provides the company with guidance on how to create long-term value, play a positive role in the society and 2 Top priority continue to operate sustainably while Business Ethics Secure leadership QUALITY RESPONSIBILITY & Responsible delivering value to all of its stake- by strengthening AND SUSTAINABILITY Strategic Enablers AND CULTURE Leadership holders. Overall, Getinge’s sustain- the offering Build a proud global organization with engaged ability approach is focused on shaping and performance the company’s performance and posi- driven people tioning future matching requirements, including analyzing potential risks. Getinge E&C work is centered around Business Ethics and Respon- 1 Passionate sible Leadership, within the Sustain- Drive productivity and efficiency employees ability Framework. The main purpose is enhancement to enable and inspire all employees to make the right decisions and to foster an open and transparent culture. 2 Intro The Team Business Context Governance Focus Areas Ethics & Compliance Report Focus Areas ANTI-BRIBERY BUSINESS CORRUPTION page 15 ANTITRUST page 17 PARTNERS page 19 In this report we will focus on describing our most material risks and focus areas As a global medical technology Getinge operates in 125 countries, Getinge has recently revised its company we provide equipment both through our own operations Supplier Code of Conduct. The aim in relation to Business Ethics and and systems within health care and through an extensive network is to increase focus on responsible Responsible Leadership. and life sciences to public and of distributors. We have learned sourcing. The result is a new Busi- private customers in 125 countries. the hard way how important it is to ness Partner Code of Conduct that We take part in public tenders secure fair competition and ensure has been extended to include all of and collaborate with business that hospitals, and taxpayers do Getinge’s business partners and has partners such as distributors and not suffer from unfair competition. a re newed focus on Human Rights. integrators. For us it is of utmost Getinge’s purchasing function is importance to manage the risk for responsible for implementing the bribery and corruption in all our new Code with support from the business transactions. Ethics & Compliance team. DATA INTERACTION WITH HEALTH TRADE PRIVACY page 21 CARE PROFESSIONALS page 24 COMPLIANCE page 26 HUMAN RIGHTS Maintaining customer trust in Getinge interacts with hospitals Our life saving products are sold With a passion for life we take the security of and safety of its and life science institutions all globally and in some extent also pride in securing the human rights products is critical for Getinge. In over the globe. The company has a to sanctioned countries. We do of both internal employees as addition, the importance of data great responsibility both in terms however never compromise with well as for individuals working privacy and the integrity of person- of patient safety, but also in terms laws and regulations and have for Getinge throughout our value al data is a constantly increasing. of how public funds are spent implemented processes to secure and supply chain. Our work with Meanwhile, the company needs to in relation to its products and compliance and integrity when Human Rights is described in the protect its most valuable assets services. Securing integrity and selling to high risk countries. Business Partner section of this re- against cyber threats. To secure transparency when interacting port. During 2021 we will continue data privacy and security we have with health care professionals and to focus on designing a dedicated formalised our related programs health care organizations is a top E&C program for Human Rights. throughout the organization. priority. 3 Intro The Team Business Context Governance Focus Areas Ethics & Compliance Report During the last few years, Getinge To Enable has invested heavily to ensure that we have the right resources and tools in I am proud of the work that place to support and inspire responsi- and Inspire we do and of each and every ble leadership. The ultimate aim is to enable right decisions and navigate employee at Getinge who For us at Getinge, Ethics and the complexities and ethical dilemmas strives to make a difference. Compliance is something that that global business often entails. And should characterize every to achieve this, we have put a great team in place to support our opera- aspect of how we do business, tions across the globe. Naturally, we with all stakeholders and a also have the formal infrastructure in and difficulties in terms of speaking longer time perspective in place, such as e-learning programs and up and raising concerns. We also want mind. We see Ethics and policies. E-learning programs, however, to be humble when we look back on will only make a difference if the infor- our previous mistakes and ensure that Compliance as responsible mation conveyed in the training actual- we learn from these in order to build a leadership and some- ly means something for each and every stronger, more responsible and long- thing that is relevant one of us. In this report, we want to term sustainable company. for all employees and share how we aspire to integrate ethics I am excited about this first Ethics and compliance in everything we do, and Compliance report, I am proud of in every business how we work together with our leaders the work that we do and of each and transaction and to ensure that the right considerations every employee at Getinge who strives decision. are made early on, that we have the to make a difference. Each decision transparent discussions and dare to is important and will take us one step speak-up when something is not right.. closer towards becoming the most A recent Nordic survey (www.nor- trusted and respected company in the dicbusinessethics.com) indicate that a MedTech industry. majority of the employees working for Nordic companies who witness ethical misconduct, do not speak up. And Anna Romberg with sales in 125 countries, we have Executive Vice President to be mindful of cultural differences Legal, Compliance & Governance 4 Intro The Team Business Context Governance Focus Areas Ethics & Compliance Report Our Governance GOVERNANCE MODEL Model for Ethics Board of Directors and Compliance Audit Committee At Getinge the Ethics and Compliance (E&C) work is designed to ensure that it is a shared commit- Ethics ment across all levels in the organization. CEO Committee The Global Legal, Compliance and adequately designed, that imple- Governance team consists of the mentation support is provided to the EVP Legal, Compliance Global Legal team, the Global Ethics & organization and that the implemen- & Governance Compliance (E&C) team and Corporate tation is followed up and reported to Internal Audit. Within the Global E&C the Audit Committee of the Board of team there is dedicated teams for Directors and Getinge Executive Team.
Load more

Recommended publications
  • 56Th Annual Meeting O Fficers and Council 5 Corporate Supporters Committee Members 6 Gl O D Past Meetings of the STSA 7
    SOU THERN THORACIC STSA SURGICAL ASSOCIatION 56 TH ANNUAL MEETING NOVE MBER 4 - 7, 2009 Marco Island Marriott Beach Resort Marco Island, Florida SPECI AL THANKS ta BLE OF CONTENTS SPECIAL THANKS TO STSA 56TH ANNUAL MEETING O FFICERS AND COUNCIL 5 CORPORATE SUPPORTERS COmmITTEE MEMBERS 6 GL O D PAST MEETINGS OF THE STSA 7 Medtronic CLIFFORD VAN METER PRESIDENT’S AWARD 8 www.medtronic.com TIKI AWARD 9 St. Jude Medical OSLER ABBOTT AWARD 10-11 www.sjm.com KENT TRINKLE EDUCATION LECTURESHIP 11 SILVER HAWLEY H SEILER, M D RESIDENT AWARD 12 Ethicon Endo-Surgery, Inc. MAVROUDIS-URSCHEL AWARD 12 www.ethiconendo.com STSA INSPIRATION AWARD 13 Maquet Cardiovascular www.maquet.com CONTINUING MEDICAL EDUCATION OVERVIEW 14-15 DISCLOSURE POLICY 16-17 SCHEDULE OF EVENTS 18-20 SCHEDULE OF ACTIVITIES 21-22 SURGICAL MOTION PICTURES 23 POSTGRADUATE PROGRAM 24-26 SCIENTIFIC SESSIONS 27-44 BASIC SCIENCE FORUM 30 GENERAL SESSION 33 CODING UPDATE AND ETHICS FORUM 40 HISTORY PRESENTATION 43 SCIENTIFIC PAPERS 45-203 EXHIBITORS 204-209 NECROLOGY REPORT 211 HONORARY MEMBERS 212 MEMBERSHIP ROSTER 213-312 GEOGRAPHIC LISTING OF MEMBERS 313-329 CONSTITUTION AND BYLAWS 330-341 RELATIONSHIP DISCLOSURE INDEX 342-350 INDEX OF AUTHORS 352-356 2 STSA 56th Annual Meeting STSA 56th Annual Meeting 3 F UTURE MEETING LOCATIONS 2009F OF ICERS AND COUNCIL N OVEMBER 3-6, 2010 P RESIDENT Disney Yacht & Beach Club Michael J Mack, MD Orlando, FL Dallas, TX NOVEMBER 9-12, 2011 PRESIDENT-ELECT JW Marriott San Antonio Hill Keith Naunheim, MD San Antonio, TX St. Louis, MO NOVEMBER 7-10,
    [Show full text]
  • ANNUAL REPORT 2020 ANNUAL REPORT 3 Introduction Q the Year in Brief the Year in Brief Q Introduction
    Passion for life 2020 Annual Report This is Getinge Q Introduction CONTENTS Introduction Passion for life This is Getinge 1 Global value creation 2 Sometime in life, we all need to seek health care. At The year in brief 4 Getinge, we have a long tradition of creating innovations CEO Interview 6 that improve people’s quality of life – and save lives. We Trends and business drivers 8 think it is the most important job in the world. Strategy Targets 12 Strategy for sustainable growth 14 Sustainability framework 18 Operations Market overview & sales 31 Acute Care Therapies 34 Life Science 38 Surgical Workflows 42 Annual Report Administration Report 47 Corporate Governance Report 56 Board of Directors 69 Getinge Executive Team 72 Guidelines for remuneration 74 Remuneration Report 79 Proposed appropriation of profit 82 Group Financial statements 83 Notes 88 Parent Company Financial statements 120 Notes 124 Auditor’s report 131 Other information Sustainability notes 136 GRI index 147 The Getinge share 150 Multi-year overview 152 Group companies 158 Definitions 162 Getinge adds value to THIS IS GETINGE customers’ operations in terms of The world is facing major challenges, one of which is the ability to provide 25,000 10,800 the increasing world population with safe and effective health care. We live longer and, according to WHO, lifestyle diseases such as cardiovascular Improved No. of customers No. of employees in the company diseases are one of the primary causes of death globally. clinical outcomes Getinge is committed to ensuring that all people and societies have access to the best possible health care.
    [Show full text]
  • Getinge Ab Annual Report 2011 Atrium Medical Sales Organic Growth Number of Employees
    geTinge ab annual reporT 2011 Atrium Medical Sales Organic growth Number of employees 200 19% 700 USD million three­year average total, worldwide A rapidly expanding company in the dynamic cardiovascular market The acquisition of the US company Atrium Medical was completed on 1 November 2011. Atrium is the latest addition to the Medical Systems Business Area’s cardio­ vascular operations. Atrium has an impressive track record and since the company was founded in 1981, it has grown rapidly, particularly over the past three years for which organic growth averaged 19% annually. The headquarters is in Hudson, New Hampshire in the US and the US market accounts for 70% of sales. The remaining 30% is through proprietary sales offices in the UK, Germany, France, the Netherlands, India, Australia and New Zealand as well as via a network of international distributors. The first product launched by Atrium was a drainage product used for open cardiovascular and thoracic surgery to remove air and fluids from the thoracic cavity and thus maintain normal respiratory function. The product is principally used for operations following severe A V12 covered stent used to repair ruptured traumas such as traffic accidents. arteries. Following this first product, Atrium has continued to develop a range of products, including synthetic vascular implants and stents using polytetrafluoroethylene (PTFE). The use of PTFE provides a number of advantages. For example, stents covered with PTFE can be rapidly inserted in the correct position to repair a ruptured artery through an operation of a minimal invasive nature. Recently, Atrium started to utilise Omega­3 fatty acids in the surgical treatment of hernias.
    [Show full text]
  • Getinge 2018 Annual Report
    Passion for life 2018 Annual Report CONTENTS Passion for life Introduction This is Getinge 1 Year in brief 2 Sometime in life, we all need to seek healthcare. At Comments by the CEO 6 Getinge, we have a long tradition of creating innovations that improve people’s quality of life – and save lives. We Business environment think it is the most important job in the world. and market trends Global value creation 10 Trends and business drivers 12 Market overview 14 Strategy and targets Strategy 18 Targets 20 R&D 22 Sales 24 Quality 25 Operations Acute Care Therapies 28 Surgical Workflows 32 Life Science 36 Sustainability Sustainable value creation 42 Ethics 46 Employees 48 Environment 50 Annual Report Administration Report 52 Corporate Governance Report 56 Proposed appropriation of profit 66 Financial statements 67 Notes 72 Auditor’s report 115 Other information Sustainability notes 119 GRI index 122 The share 124 Multi-year overview 126 Group companies 131 Definitions 135 Every care has been taken in the translation of this Annual Report. In the event of discrepancies, the Swedish original will supersede the English translation. Cover: Mickaël Fresnay and Jason Courtin, DPTE® Transfer System Fitters at Getinge’s production facility in Vendôme, France. 2018 ANNUAL REPORT Introduction Market Strategy Operations Sustainability Annual Report Other This is Getinge The world is facing major challenges, one of which is the possibility to provide people with high-quality and effective healthcare. The Earth’s population is increasing, while we are also living longer, which increases the pressure on healthcare. According to the WHO, lifestyle diseases, such as cardiovascular diseases are one of the primary causes of death in the world.
    [Show full text]
  • Reporting Period January – December
    Getinge Group Q4 Report 2008 Reporting period January – December ♦ Orders received increased by 17.9% to SEK 19,447 million (16,497), corresponding to organic growth of 7.1% ♦ Orders received for the quarter increased by 23.6% to SEK 5,638 million (4,563), corresponding to organic growth of 5.1% ♦ Net sales rose by 17.2% to SEK 19,272 million (16,445) ♦ Profit before tax increased by 21.4% to SEK 2,155 million (1,775) ♦ Net profit increased by 23.1% to SEK 1,552 million (1,260) ♦ Earnings per share increased by 23.5% to SEK 7.37 (5.97) ♦ Dividend per share proposed at SEK 2.40 (2.40), corresponding to SEK 572 million (515), an increase of 11 % ♦ EBITA before restructuring increased by 29.1% to SEK 3,456 million (2,678) ♦ Acquisition of Datascope Corp is expected to be completed shortly Fourth quarter 2008 Getinge’s earnings trend remained strong during the quarter and met our expectations, although the trend varied at the business area level. Despite the risk of weakening demand in some of our markets, we expect to continue growing more rapidly than the underlying market, with major potential for improving our profitability in line with our financial goals. Orders received Orders received by the Group increased organically by 5.1% for the period. Thus, orders received for the full year increased organically by a healthy 7.1%. The volume trend for the Group was generally very good in most of the geographic regions, with the exception of the US market, where growth in all business areas declined to varying degrees.
    [Show full text]
  • Why Invest in Turkish Medical Technologies Industry?
    WHY INVEST IN TURKISH MEDICAL TECHNOLOGIES INDUSTRY? 1 invest.gov.tr AGENDA 1 Executive Summary 4 Opportunities in Turkish MedTech Industry Turkish MedTech 2 5 Industry Outlook Site Assessment 3 Growth Drivers in Turkey 2 investinvest.gov.tr.gov.tr EXECUTIVE SUMMARY TURKEY IS BECOMING A HUB FOR MEDICAL TECHNOLOGIES BY OFFERING OPPORTUNITIES IN MANY AREAS... • Strong macroeconomic growth with increasing income per capita and a bourgeoning middle class FAVORABLE • Favorable demographics with a dynamic, young and skilled talent pool supporting the industry INVESTMENT • Increasing life expectancy and spending in healthcare ENVIRONMENT • Strong government support through manufacturing and R&D incentives • With Healthcare Transformation Program and Universal Healthcare Insurance launched in 2003, Turkish government assures free healthcare coverage to 95% of the population ROBUST GROWTH • Turkish medical devices market has seen a robust growth over the past IN THE SECTOR decade – ranks 3rd in CEE with $2 Billion in value • Export opportunities due to Turkey’s proximity to regional markets • Turkey’s localization program in action to reduce import dependency and increase local production • Heavy investments in healthcare infrastructure and services LUCRATIVE OPPORTUNITIES IN SUB-SECTORS • Strong government support for biotechnology • Ideal location for medical tourism and a favorable regulatory environment aligned with international standards STRONG INTERNATIONAL • Global medical technology companies have been present in Turkey with significant
    [Show full text]
  • Annual Report Innovative Solutions That Help Solve Healthcare Challenges
    Innovative solutions that help solve healthcare challenges Annual Report 2014 Content GROUP 2014 in brief . 1 Introducing Getinge . 2 Comments by the CEO . 4 Business Drivers . 6 Strategy . 10 Values and Culture . 16 Innovation . 18 Sustainability Report . 22 Business Area Overview . 30 Medical Systems Business Area . 32 Extended Care Business Area . 38 Infection Control Business Area . 44 The Getinge Share . 50 FINANCIAL INFORMATION Administration Report . 52 Corporate Governance Report . 56 Internal Control Report . 61 Getinge’s Board of Directors . 62 Getinge’s Group Management . 64 Proposed Allocation of Profits . 66 Consolidated Financial Statements 67 Income Statement . 67 Statement of Comprehensive Income . 67 Balance Sheet . 68 Changes in Shareholders’ Equity . 69 Cash-flow Statement . 70 Notes . 71 Parent Company . 91 Income Statement . 91 Statement of Comprehensive Income . 91 Balance Sheet . 92 Changes in Shareholders’ Equity . 93 Cash-flow Statement . 93 Notes . 94 Auditor’s Report . 98 GETINGE INFORMATION Multi-year Overview, Group . 99 Multi-year Overview, Business Areas . 100 Largest Markets . 101 Market Organization . 101 Acquisition History . 102 Quarterly Data . 103 Our success will be driven by our Quality & Environmental Certifications . 104 Environmental Data . 104 dedication to solve customer challenges Social Data . 104 Addresses . 105 with innovative solutions that save OTHER lives and ensure excellent care. Definitions . 110 Reading Guide . 110 Distribution Policy . 110 AGM & Nomination Committee . 111 OUR MISSION Financial Information . 112 Disclaimer. The information in this annual report is intended for an international audience outside of the United States. 2014 in brief USA & Canada Order intake + 5,6 % SEK 26 817 M (25 395) . Organic Increase: +0,7 % +5% Net sales + 5,5 % SEK 26 669 M (25 287) .
    [Show full text]
  • Passion for Life 2019 Annual Report CONTENTS
    Passion for life 2019 Annual Report CONTENTS Introduction This is Getinge 1 Global value creation 2 CEO comments 4 Business environment and strategy COLLABORATION Trends and business drivers 10 Market overview 12 Strategy 14 Targets 16 Strategic activities 18 Operations Acute Care Therapies 24 Surgical Workflows 28 Life Science 32 Sustainability A sustainable offer 38 Responsible sourcing 42 Employees 46 OPENNESS Business ethics 50 Annual Report Administration Report 54 Corporate Governance Report 58 Board of Directors 66 Getinge Executive Team 68 Guidelines for remuneration 70 Proposed appropriation of profit 72 Group Financial statements 73 Notes 78 Parent Company Financial statements 110 Notes 114 Auditor’s report 121 EXCELLENCE Other information Sustainability notes 126 GRI index 130 The Getinge share 132 Multi-year overview 134 Group companies 139 Definitions 143 Every care has been taken in the translation of this Annual Report. In the event of discrepancies, the Swedish original will supersede the English translation. Cover: Lisa Kuehn, working at Getinge’s OWNERSHIP production site in Rastatt, Germany. 2019 ANNUAL REPORT Business Environment Introduction & Strategy Operations Sustainability Annual Report Other Passion for life Sometime in life, we all need to seek health care. At Getinge, we have a long tradition of creating innovations that improve people’s quality of life – and save lives. We think it is the most important job in the world. This is Getinge The world is facing major challenges, one of which is the abil- ity to provide the increasing world population with safe and effective health care. People are living longer and, according to WHO, lifestyle diseases such as cardiovascular diseases are one of the primary causes of death globally.
    [Show full text]